MiR-5096, as a potential target of the KCNJ10 gene, can decrease Kir4.1 channel protein expression in GBM cells, and miR-5096 and Kir4.1 knockdown can increase glioma cell invasiveness (41). This evidence concerns the gene KCNJ10 and glioblastoma.